James F. Polewaczyk - 14 Feb 2023 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Role
Executive Vice President
Signature
/s/ Lily J. Lu, Attorney-in-Fact for James F. Polewaczyk
Issuer symbol
IDXX
Transactions as of
14 Feb 2023
Net transactions value
+$126,920
Form type
4
Filing time
16 Feb 2023, 17:54:36 UTC
Previous filing
10 Feb 2023
Next filing
31 Aug 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IDXX Common Stock Options Exercise $0 +126 +0.82% $0.000000 15,555 14 Feb 2023 Direct F7
transaction IDXX Common Stock Options Exercise $0 +127 +0.82% $0.000000 15,682 14 Feb 2023 Direct
transaction IDXX Common Stock Options Exercise $0 +216 +1.4% $0.000000 15,898 14 Feb 2023 Direct
transaction IDXX Common Stock Options Exercise $0 +161 +0.98% $0.000000 16,605 14 Feb 2023 Direct
transaction IDXX Common Stock Options Exercise $0 +204 +1.3% $0.000000 16,263 14 Feb 2023 Direct
transaction IDXX Common Stock Tax liability $126,920 +252 +1.6% $503.65 16,011 14 Feb 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDXX Restricted Stock Unit Options Exercise -126 -4.2% 2,863 14 Feb 2023 Common Stock 126 Direct F1, F6
transaction IDXX Restricted Stock Unit Options Exercise -127 -4.4% 2,736 14 Feb 2023 Common Stock 127 Direct F2, F6
transaction IDXX Restricted Stock Unit Options Exercise -216 -7.9% 2,520 14 Feb 2023 Common Stock 216 Direct F3, F6
transaction IDXX Restricted Stock Unit Options Exercise -161 -6.4% 2,359 14 Feb 2023 Common Stock 161 Direct F4, F6
transaction IDXX Restricted Stock Unit Options Exercise -204 -8.6% 2,155 14 Feb 2023 Common Stock 204 Direct F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in five annual installments, beginning February 14, 2019.
F2 Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2020.
F3 Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2021.
F4 Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2022.
F5 Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2023.
F6 Not applicable.
F7 Adjusted to include 1 additional share of Issuer common stock due to a scrivener's error.